Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes

European Respiratory Journal

Volumn 38, Issue 3, 2011, Pages 672-678

  Kukkonen, M K ^a   Hamalainen S ^a   Kaleva, S ^a   Vehmas, T ^a   Huuskonen, M S ^a   Oksa, P ^a   Vainio, H ^a   Piirila P ^a   Hirvonen, A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Asbestos; Fibrosis; Pleural plaques; Polymorphism; Xenobiotic metabolising enzyme

Indexed keywords

ASBESTOS; CARBON MONOXIDE;

ADULT; ARTICLE; ASBESTOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME METABOLISM; EPHX1 GENE; ETHNICITY; FEMALE; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM1 GENE; GSTM3 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; LUNG CAPACITY; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; NAT2 GENE; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PLEURA PLAQUE; PLEURA THICKENING; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; ASBESTOS; FEMALE; FIBROSIS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; PULMONARY FIBROSIS; QUALITY CONTROL; RISK FACTORS; XENOBIOTICS;

EID: 80053070200     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00049810     Document Type: Article

References (37)

1. Manning CB, Vallyathan V, Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2002; 2: 191-200. (Pubitemid 34075410)
2. Mossman BT, Gee JB. Asbestos-related diseases. N Engl J Med 1989; 320: 1721-1730. (Pubitemid 19163128)
3. Miller A, Lilis R, Godbold J, et al. Relationship of pulmonary function to radiographic interstitial fibrosis in 2,611 long-term asbestos insulators. An assessment of the International Labour Office profusion score. Am Rev Respir Dis 1992; 145: 263-270.
4. Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest 2004; 125: 1103-1117. (Pubitemid 38367306)
5. Neri M, Ugolini D, Dianzani I, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res 2008; 659: 126-136.
6. Guengerich FP, Thier R, Persmark M, et al. Conjugation of carcinogens by theta class glutathione S-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics 1995; 5: S103-S107.
7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600.
8. Smith CM, Kelsey KT, Wiencke JK, et al. Inherited glutathione- Stransferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers Prev 1994; 3: 471-477. (Pubitemid 24280970)
9. Franko A, Dodic-Fikfak M, Arneric N, et al. Glutathione Stransferases GSTM1 and GSTT1 polymorphisms and asbestosis. J Occup Environ Med 2007; 49: 667-671. (Pubitemid 46918859)
10. Franko A, Dolzan V, Arneric N, et al. The influence of genetic polymorphisms of GSTP1 on the development of asbestosis. J Occup Environ Med 2008; 50: 7-12.
11. Jakobsson K, Rannug A, Alexandrie AK, et al. Genetic polymorphism for glutathione-S-transferase m in asbestos cement workers. Occup Environ Med 1994; 51: 812-816. (Pubitemid 24368131)
12. Jakobsson K, Rannug A, Alexandrie AK, et al. Radiographic changes and lung function in relation to activity of the glutathione transferases h and m among asbestos cement workers. Toxicol Lett 1995; 77: 363-369.
13. Kelsey KT, Nelson HH, Wiencke JK, et al. The glutathione Stransferase θ and μ deletion polymorphisms in asbestosis. Am J Ind Med 1997; 31: 274-279. (Pubitemid 27097776)
14. Hein DW, Doll MA, Rustan TD, et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993; 14: 1633-1638. (Pubitemid 23249371)
15. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506-507: 65-77. (Pubitemid 35286541)
16. Hirvonen A, Pelin K, Tammilehto L, et al. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995; 55: 2981-2983.
17. Hirvonen A, Saarikoski ST, Linnainmaa K, et al. Glutathione Stransferase and N-acetyltransferase genotypes and asbestosassociated pulmonary disorders. J Natl Cancer Inst 1996; 88: 1853-1856. (Pubitemid 26425061)
18. Neri M, Taioli E, Filiberti R, et al. Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: a comparison of Finnish and Italian populations. Int J Hyg Environ Health 2006; 209: 393-398. (Pubitemid 43929421)
19. Fretland AJ, Omiecinski CJ. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 2000; 129: 41-59. (Pubitemid 32061053)
20. Inskip A, Elexperu-Camiruaga J, Buxton N, et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J 1995; 312: 713-716. (Pubitemid 26005978)
21. Liu X, Campbell MR, Pittman GS, et al. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation. Cancer Res 2005; 65: 99-104. (Pubitemid 40070800)
22. Huuskonen O, Kivisaari L, Zitting A, et al. High-resolution computed tomography classification of lung fibrosis for patients with asbestos-related disease. Scand J Work Environ Health 2001; 27: 106-112. (Pubitemid 32440346)
23. Tiitola M, Kivisaari L, Zitting A, et al. Computed tomography of asbestos-related pleural abnormalities. Int Arch Occup Environ Health 2002; 75: 224-228. (Pubitemid 36075107)
24. Vierikko T, Järvenpää R, Autti T, et al. Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Respir J 2007; 29: 78-84. (Pubitemid 46092001)
25. Voho A, Impivaara O, Jarvisalo J, et al. Distribution of glutathione Stransferase M1, P1 and T1 genotypes in different age-groups of Finns without diagnosed cancer. Cancer Detect Prev 2006; 30: 144-151. (Pubitemid 43766237)
26. Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 41-52.
27. Viljanen AA. Reference values for spirometric, pulmonary diffusing capacity and body plethysmographic studies. Scand J Clin Invest 1982; 42: Suppl. 159, 1-50.
28. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999; 81: 44-48. (Pubitemid 29124195)
29. Saarikoski ST, Voho A, Reinikainen M, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 1998; 77: 516-521. (Pubitemid 28340896)
30. Lancaster JM, Brownlee HA, Bell DA, et al. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 1996; 17: 160-162. (Pubitemid 26408191)
31. Spurdle AB, Purdie DM, Webb PM, et al. The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer. Mol Carcinog 2001; 30: 71-78. (Pubitemid 32127352)
32. Sillanpaa P, Hirvonen A, Kataja V, et al. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer 2005; 114: 579-584. (Pubitemid 40349616)
33. Cascorbi I, Roots I. Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics 1999; 9: 123-127. (Pubitemid 29176731)
34. Vatsis KP, Weber WW, Bell DA, et al. Nomenclature for Nacetyltransferases. Pharmacogenetics 1995; 5: 1-17.
35. Benhamou S, Reinikainen M, Bouchardy C, et al. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998; 58: 5291-5293. (Pubitemid 28551101)
36. Nielsen DM, Ehm MG, Weir BS. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 1998; 63: 1531-1540. (Pubitemid 30418550)
37. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46. (Pubitemid 20255621)